Predicting immunotherapy effectiveness in late-stage liver cancer
By Richard Schoonraad | Cancer, Cancer, Funding, Immunotherapy, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, ResearchBlood test could hold key to identifying who will respond to immunotherapy after researchers discover biomarkers in liver cancer tissue. Liver cancer researchers at the Harry Perkins Institute of Medical…
World melanoma expert exposes sailor’s skin cancer risk
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Melanoma, Melanoma Discovery, Melonoma, News & Events, ResearchPerth based cancer researcher Professor Jonas Nilsson regularly sees in his laboratory just how damaging sun exposure is to our skin as he investigates ways to treat melanoma, the most…
New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
Federal government supports new treatment to clear blocked arteries
By Richard Schoonraad | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, ResearchA Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…
WA researchers excel in nationally competitive grants
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial Disease, Mitochondrial disease, Mitochondrial Medicine and Biology, News & Events, Research, TranslationEight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…
Australian Cancer Plan consultation period open
By Richard Schoonraad | Cancer, Cancer, Cancer Centre News, News & EventsFurther to the Federal Government commitment of $375M to establish the Perkins-led WA Comprehensive Cancer Centre, the Government has been consulting with stakeholders to develop the Australian Cancer Plan. This…
$3.5 million research collaborative brings cell therapy for solid cancers to WA
By Richard Schoonraad | Cancer, Cancer, Funding, Melanoma, Melanoma Discovery, Melonoma, News & Events, Personalised Medicine, ResearchResearchers from the Western Australia Melanoma Initiative (WAMI), a cancer research collaborative, will implement a specialised immune cell therapy for cancer patients in WA, thanks to a $2.5 million grant…
Perkins welcomes release of Australian Cancer Plan
By Richard Schoonraad | Cancer, Cancer, Cancer Centre News, News & EventsStatement from Professor Peter Leedman AO, Director, Harry Perkins Institute of Medical Research, on the release of the Australian Cancer Plan: The Harry Perkins Institute of Medical Research (the Perkins)…